Follicular thyroid cancer medical therapy: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NTOC__ {{Follicular thyroid cancer}} {{CMG}}; {{AE}} {{Ammu}} ==Overview== ==Medical Therapy== ===Targeted Therapy=== ====Kinase Inhibitors==== * Sorafenib * Lenvatinib")
 
No edit summary
Line 1: Line 1:
__NTOC__
__NoTOC__
{{Follicular thyroid cancer}}
{{Follicular thyroid cancer}}
{{CMG}}; {{AE}} {{Ammu}}
{{CMG}}; {{AE}} {{Ammu}}
Line 6: Line 6:
===Targeted Therapy===
===Targeted Therapy===
====Kinase Inhibitors====
====Kinase Inhibitors====
* Sorafenib
* Sorafenib
* Lenvatinib
* Lenvatinib

Revision as of 16:19, 26 October 2015

Follicular thyroid cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Follicular thyroid cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

X-ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Follicular thyroid cancer medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Follicular thyroid cancer medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Follicular thyroid cancer medical therapy

CDC on Follicular thyroid cancer medical therapy

Follicular thyroid cancer medical therapy in the news

Blogs on Follicular thyroid cancer medical therapy

Directions to Hospitals Treating Follicular thyroid cancer

Risk calculators and risk factors for Follicular thyroid cancer medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]

Overview

Medical Therapy

Targeted Therapy

Kinase Inhibitors

  • Sorafenib
  • Lenvatinib